Postoperative analgesia of thoracoscopy
Conditions
Interventions
C1:At the end of the operation, intercostal nerve block was performed with 0.5% ropivacaine and 10mg dexamethasone
C2:At the end of the operation, intercostal nerve block was performed with 0.5% ropivacaine and Dexmedetomidine 1ug/kg
C3:At the end of the operation, intercostal nerve block was performed with 0.5% ropivacaine and 10mg dexamethasone and Dexmedetomidine 1ug/kg
A:At the end of the operation, intercostal nerve block was performed with 0.5% ropivacaine
Sponsors
The First Affiliated Hospital with Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with American Society of Anesthesiologists(ASA)physical status I-II, aged 18-65yr, and scheduled for unilateral thoracoscopic surgery.
Exclusion criteria
Exclusion criteria: Patient with hypohepatia,renal insufficiency,severe heart or lung disease, sereve arrhythmia,drug allery (amide local anesthetic, hormone, dexmedetomidine), chroinc sedative use, chronic analgesic use, chronic systemic corticosteroid use,chronic pain syndrome, Pleural lesion, history of thoracic surgery, consciousness disorder or unable to understand the visual analogue scale(VAS), with contraindications to intercostal nerve block (such coagulopathy,anatomic variation, local anesthetic allergy) and patient refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ramsay score;The first compression time of the analgesic pump; | — |
Countries
China
Contacts
Public ContactCunming Liu
The First Affiliated Hospital with Nanjing Medical University
Outcome results
None listed